Arteris, Inc. (NASDAQ:AIP) Sees Significant Decrease in Short Interest

Arteris, Inc. (NASDAQ:AIP) was the recipient of a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 308,100 shares, a decline of 21.2% from the November 30th total of 391,100 shares. Currently, 1.2% of the company’s shares are short sold. Based on an average daily volume of 143,300 shares, the short-interest ratio is currently 2.2 days.

Wall Street Analysts Forecast Growth

Separately, Rosenblatt Securities reissued a “buy” rating and issued a $15.00 target price on shares of Arteris in a research note on Wednesday, November 6th.

Insider Buying and Selling

In related news, CEO K Charles Janac sold 5,520 shares of Arteris stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $7.18, for a total value of $39,633.60. Following the sale, the chief executive officer now owns 287,247 shares of the company’s stock, valued at approximately $2,062,433.46. This trade represents a 1.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Nicholas B. Hawkins sold 5,000 shares of the stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $7.35, for a total transaction of $36,750.00. Following the completion of the sale, the chief financial officer now directly owns 219,659 shares of the company’s stock, valued at approximately $1,614,493.65. This trade represents a 2.23 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 119,063 shares of company stock valued at $1,055,822 over the last quarter. 33.70% of the stock is owned by corporate insiders.

Institutional Trading of Arteris

Several large investors have recently added to or reduced their stakes in AIP. US Bancorp DE acquired a new position in Arteris in the 3rd quarter worth about $34,000. Renaissance Technologies LLC increased its position in shares of Arteris by 6.1% during the 2nd quarter. Renaissance Technologies LLC now owns 114,700 shares of the company’s stock worth $861,000 after purchasing an additional 6,600 shares in the last quarter. MetLife Investment Management LLC boosted its position in Arteris by 129.1% in the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after buying an additional 9,551 shares in the last quarter. The Manufacturers Life Insurance Company acquired a new stake in shares of Arteris during the second quarter worth approximately $86,000. Finally, Franklin Resources Inc. boosted its holdings in shares of Arteris by 0.8% in the 3rd quarter. Franklin Resources Inc. now owns 1,491,415 shares of the company’s stock worth $11,201,000 after acquiring an additional 12,375 shares in the last quarter. 64.36% of the stock is currently owned by institutional investors and hedge funds.

Arteris Stock Up 0.2 %

NASDAQ AIP traded up $0.02 during mid-day trading on Monday, reaching $10.29. 54,855 shares of the company’s stock traded hands, compared to its average volume of 169,070. The company has a market cap of $413.42 million, a price-to-earnings ratio of -10.72 and a beta of 1.25. The company has a fifty day simple moving average of $8.50 and a 200-day simple moving average of $7.95. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. Arteris has a 1-year low of $4.83 and a 1-year high of $10.69.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.